Investing.com - Oscar Health (NYSE: OSCR) reported second quarter EPS of $-0.07, $0.15 better than the analyst estimate of $-0.22. Revenue for the quarter came in at $1.52B versus the consensus estimate of $1.38B.
Oscar Health's stock price closed at $7.12. It is up 1.42% in the last 3 months and up 12.66% in the last 12 months.
Oscar Health saw 2 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Oscar Health's stock price’s past reactions to earnings here.
According to InvestingPro, Oscar Health's Financial Health score is "fair performance".
Check out Oscar Health's recent earnings performance, and Oscar Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar